Emotional Face Perception in Patients with Schizophrenia: an Event-Related Potential Study by Akbarfahimi, M. et al.
NEUROPHYSIOLOGY	/	НЕЙРОФИЗИОЛОГИЯ.—2013.—T.	45,	№	3 279
UDC 612.822:547.918
M.	AKBARFAHIMI,1,2	M.	TEHRANI-DOOST,3,1	and	F.	GHASSEMI4,1 
EMOTIONAL FACE PERCEPTION IN PATIENTS WITH SCHIZOPHRENIA:  
AN EVENT-RELATED POTENTIAL STUDY
Received	December	15,	2012.
Emotional	face	recognition	has	been	shown	to	be	drastically	 impaired	among	patients	with	
schizophrenia.	Since	the	underlying	processes	of	this	deficit	have	not	been	widely	addressed,	
we	attempted	to	investigate	the	relationship	between	facial	expression	perception	and	clini-
cal	symptoms	in	patients	with	schizophrenia.	We	enrolled	28	patients	with	schizophrenia	and	
28	 healthy	 adults	matched	 by	 their	 sex	 and	 age.	The	 amplitude	 and	 latency	 of	 component	
N170	in	event-related	EEG	potentials	(ERPs)	induced	by	presentations	of	happy,	fearful,	and	
neutral	face	images	were	comparatively	evaluated	in	these	two	groups.	Furthermore,	the	re-
lationship	between	the	N170	measures	and	clinical	symptoms	of	schizophrenia	were	assessed	
using	 the	 Positive	 and	 Negative	 Syndrome	 Scale	 (PANSS).	 The	 N170	 responses	 to	 facial	
expressions	in	patients	with	schizophrenia	were	significantly	delayed,	as	compared	to	healthy	
control	 participants	 [F	 (1,	 54)	 =	 4.25,	P	 =	 0.044].	 The	 N170	 response	 to	 fearful	 faces	 (as	
compared	to	happy	and	neutral	faces)	was	elicited	with	the	minimum	latency	in	the	control	
group,	while	this	component	was	most	delayed	among	schizophrenics.	Positive	schizophrenia	
symptoms	correlated	with	the	amplitudes	of	the	left-hemisphere	N170	component	in	response	
to	happy,	 fearful,	 and	neutral	 faces.	Our	 findings	 suggest	 that	 the	 facial	 expression	deficit	
in	schizophrenia	is	related	to	delayed	responses	in	face	perception	and	is	influenced	by	the	
severity	of	positive	symptoms.	The	evident	delay	in	fearful	face	perception	among	patients	
with	schizophrenia	may	partly	explain	their	inappropriate	reactions	to	threatening	conditions.
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INTRODUCTION
Schizophrenia	is	a	severe	mental	illness	encompassing	
a	 spectrum	 of	 cognitive,	 social,	 and	 emotional	
impairments	 [1]	 and	 characterized	 by	 negative	 and	
positive	symptoms	[2].	Despite	compelling	evidence	on	
deficient	emotional	face	perception	and	recognition	in	
patients	with	schizophrenia,	the	processes	underlying	
these	deficits	are	still	open	to	debate	[3].		Elucidating	
the	 possible	 underlying	 causes	 for	 emotional	 face	
processing	 disorder	 in	 schizophrenia	 would	 help	
to	 suggest	 effective	 treatment	 interventions	 and	
remediation	 strategies.	 The	 three	 main	 hypotheses	
of	 this	 impairment	 are	 the	 following:	 (i)	 cognitive	
impairment	 [4],	 (ii)	 early-stage	 visual	 processing	
deficits	[1],	and	(iii)	general	deficit	in	face	or	particular	
emotional	 face	processing	 [5,	6].	 In	 terms	of	general	
deficiency	 in	 facial	 recognition,	 some	 behavioral	
studies	 indicated	 that	 patients	 with	 schizophrenia	
suffer	from	an	incapability	of	recognizing	face	identity	
(i.e.,	age,	sex,	etc.)	[7],	distinguishing	face	familiarity	
vs	 unfamiliarity	 [5],	 and/or	 providing	 face	 detection	
[8].	A	 different	 approach	 has	 emphasized	 the	 role	 of	
emotion-specific	disorder	in	perception	and	recognition	
of	 facial	expressions	 [9].	 	According	 to	Strauss	et	al.	
[10],	 patients	 with	 schizophrenia	 have	 difficulties	
in	 recognizing	 emotional	 faces	 during	 labeling	 or	
matching	tasks	for	different	emotional	faces.	Schneider	
et	 al.	 [11]	 reported	 that	 schizophrenia	 patients	 have	
a	 weaker	 performance	 in	 emotional	 recognition	
tasks	 even	 in	 easily	 recognizable	 emotions,	 like	
happiness,	 without	 any	 deficit	 in	 age-discrimination	
tasks,	 as	 compared	 to	 control	 subjects	 [11].	 Various	
neural	 networks	 are	 assumed	 to	 be	 involved	 during	
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processing	 of	 distinct	 facial	 emotions.	 For	 instance,	
the	 amygdala	 has	 often	 been	 linked	 to	 fearful	 and	
sad	 face	 processing,	 the	 cingulate	 sulcus	 and	 orbital	
frontal	 cortical	 regions	 are	 shown	 to	 be	 activated	 by	
viewing	 of	 happy	 and	 angry	 faces,	 respectively,	 and	
the	basal	ganglia	and	insula	are	activated	in	response	to	
disgust	faces	[12].	Evidence	from	functional	magnetic	
resonance	 imaging	 (fMRI)	 studies	 has	 explained	
some	 anatomical	 underpinnings	 of	 the	 deficits	 in	
emotional	 face	 processing,	 such	 as	 hypoactivity	
of	 the	 ventral	 temporal	 cortex,	 basal	 ganglia,	 and	
prefrontal	cortex	[13],	as	well	as	hyperactivity	of	the	
left	 hippocampal	 structures	 and	 right	 amygdala	 [14]	
among	 schizophrenics.	 	 In	 addition,	 some	behavioral	
studies	 have	 substantiated	 deficits	 in	 recognizing	
negative	 emotions	 during	 emotion	 identification	 and	
discrimination	tasks	[6],	while	others	emphasized	the	
impairment	in	recognizing	particular	emotional	faces,	
such	 as	 fearful	 [15],	 disgusted	 [5,	 15],	 angry,	 and/or	
sad	[16].
Among	 the	variety	of	methods	used	 in	 face	 recog-
nition	 studies,	 recording	 of	 event-related	 potentials	
(ERPs)	is	one	of	the	most	well-established	techniques	
currently	applied	to	investigate	the	time	course	of	neu-
ral	 responses	 to	different	 facial	expressions.	The	key	
component	 in	 the	 face	 and	 facial	 expression	 studies	
using	ERPs	 is	 the	 	N170	deflection	 [17,	18].	Recent	
studies	demonstrated	that	patients	with	schizophrenia	
exhibit	 reduced	N170	amplitudes	during	neutral	 and	
emotional	 face	processing	[19-21].	Campanella	et	al.	
[22]	demonstrated	the	absence	of	“fear	N170”	modula-
tion	in	schizophrenia.	On	the	other	hand,	while	Bediou	
et	al.	 [23]	 recorded	 the	decreased	N170	amplitude	 in	
the	schizophrenia	group	during	emotional	face	detec-
tion	 (fear,	happiness,	disgust,	 surprise,	 and	neutral),	
they	did	not	report	such	a	phenomenon	during	gender	
detection	tasks.
The	 specific	 contributions	 of	 schizophrenia	 sym-
ptoms	 to	 impairment	 in	 emotional	 face	 processing	
are	 still	 controversial	 [24].	 Some	 findings	 indicated	
that	 patients	with	 schizophrenia	 exhibit	 a	 cross-link	
bet	ween	 emotional	 faces	 but	 not	 age	 recognition	
with	 regard	 to	 the	 severity	 of	 negative	 and	 positive	
symptoms	 of	 the	 disease	 	 [7].	 	 Meanwhile,	 some	
researchers	 reported	 associations	 between	 positive	
symptoms,	age,	and	 facial	emotion	 recognition	 [25].	
In	 contrast,	 van’t	Wout	 et	 al.	 [26]	 found	 that,	 in	 the	
“schizophrenia	 with	 fear	 deficits”	 group,	 negative	
symptoms	prevail.	 In	 the	ERP	studies,	 some	authors	
reported	no	relationship	between	the	N170	parameters	
and	sub-scales	of	the	Positive	and	Negative	Syndrome	
Scale	 (PANSS)	 [5,	 27,	 28],	 while	 others	 suggested	
a	 strong	 association	 between	 the	 N170	 indices	 and	
negative	symptoms	using	the	“Scale	for	the	Assessment	
of	Negative	Symptoms”	(SANS)	global	scores	[29].
Despite	 extensive	 attempts	 to	 investigate	 the	
impairment	 of	 facial	 expression	 recognition	 and	
perception	 in	 schizophrenia,	 at	 present	 there	 are	
limited	ERP	studies	explaining	the	time	course	of	each	
emotional	 face	perception.	Very	 few	such	 researches	
examined	the	relationship	between	clinical	symptoms	
and	 facial	 expression	perception.	The	main	goals	 of	
our	 study	 were:	 (i)	 to	 compare	 the	 amplitude	 and	
latency	 of	 the	 N170	 component	 between	 patients	
with	 schizophrenia	 and	 matched	 healthy	 adults	
while	 viewing	 emotional	 faces,	 and	 (ii)	 to	 examine	
the	 relationship	 between	 the	 amplitude	 and	 latency	
of	 N170	 and	 the	 severity	 of	 positive	 and	 negative	
symptoms	in	schizophrenia. 
METHODS
Participants. Thirty	 patients	 suffering	 from	
schizophrenia	(16	man	and	14	women)	and	34	healthy	
controls	 (19	 men	 and	 15	 women)	 were	 enrolled	 in	
the	study.	All	control	participants	and	schizophrenics	
were	right-handed	(based	on	the	Edinburgh	inventory)	
[30]	 and	matched	 by	 age,	 sex,	 and	 their	 educational	
levels. Diagnostic	 criteria	 for	 schizophrenia	 were	
assessed	 through	 a	 semi-structured	 diagnostic	
interview	 (Schedule	 for	 Schizophrenia	 and	Affective	
Disorder,	 SADS)	 [31]	 administered	 by	 a	 psychiatrist	
and	 also	 through	 case-file	 reviews.	 	 Patients	 were	
confirmed	not	to	have	other	psychiatric	co-morbidities	
on	 DSM-IV-TR	Axis	 I.	 	 Patients	 with	 schizophrenia	
were	recruited	from	the	Roozbeh	Psychiatry	Hospital,	
Tehran	 University	 of	 Medical	 Science	 (TUMS),	
Tehran,	Iran.	Patients	were	enrolled	during	their	stable	
chronic	 phase	 of	 schizophrenia.	 Healthy	 participants	
were	free	from	any	Axis	I	or	Axis	II	disorders,	history	
of	 schizophrenia,	 or	 other	 psychiatric	 disorders	 in	
their	 first-degree	 relatives.	 Across	 groups,	 the	 age	
varied	between	20	to	45	years,	and	the	subjects	had	≥	9	
years	 of	 formal	 education	 with	 normal	 or	 corrected-
to-normal	visual	acuity.	Among	the	exclusion	criteria,	
there	 were	 a	 history	 of	 neurological	 disorders,	 loss	
of	 consciousness	 due	 to	 a	 head	 injury,	 substance	
dependence	 or	 history	 of	 substance	 abuse	within	 the	
preceding	six	months,	a	medical	condition	that	might	
affect	cerebral	functioning,	and	verbal	IQ	<	75.	
Evaluation of Clinical Symptoms.	 Evaluation	
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of	 psychopathological	 symptoms	 was	 performed	
according	 to	 the	 PANSS.	 This	 instrument	 consists	
of	 30	 clearly	 defined	 items.	 The	 PANSS	 entails	
three	subscales	 to	assess	positive	 (7	 items),	negative	 
(7	 items),	and	general	psychopathological	 (16	 items)	
symptoms	[32].	
Task and Original Stimuli. 	 The	 participants	
viewed	 all	 the	 stimuli	 presented	 on	 a	 17-inch	 LG	
monitor	screen,	 in	a	dark	and	quiet	 room,	while	 they	
were	 comfortably	 seated	 on	 a	 chair	with	 their	 head	
positioned	and	fixed	on	a	chin	rest.	The	distance	from	
the	monitor	was	60	cm,	with	an	approximately	8×11	
deg	visual	angle.	The	experiment	included	one	practice	
and	ten	experimental	blocks.	Each	experimental	block	
comprised	 presentations	 of	 five	 happy,	 sad,	 angry,	
fearful,	 and	neutral	 face	 images	of	 Iranian	validated	
peoples.	To	maintain	the	vigilance	throughout	the	task,	
a	 house	 image	 (with	 a	 10%	 probability	 of	 the	 total	
number	 of	 stimuli)	was	 used	 as	 the	 target	 stimulus.	
The	participants	were	instructed	to	press	on	the	space	
bar	using	 their	 left	 index	 finger	when	 responding	 to	
the	target	stimuli.
All	 face	 images	were	 in	 grayscale,	 oval-trimmed	
(to	 remove	 background,	 clothing,	 and	 hairline),	
and	 positioned	 within	 a	 rectangular	 frame	 (261	 ×	
365	pixel	array).	 	Each	 face	was	 repeated	100	 times	
randomly.	 The	 pictures	 were	 viewed	 for	 500	 msec	
and	instantly	replaced	by	a	white	fixation	point	in	the	
light	gray	background	(1024	×	768	pixels)	during	the	
1,000-msec-long	interstimulus	interval	(ISI)	with	±100	
msec	randomization.	The	stimuli	were	presented	at	the	
middle	of	 the	monitor	screen	using	Eevoke	software.	
Our	aim	was	to	comparatively	assess	the	responses	to	
happy	 (positive	 facial	 expression),	 fearful	 (negative	
facial	 expression),	 and	neutral	 faces.	This	was	done	
through	 analyzing	 ERP	 records	 in	 response	 to	 the	
above	(happy,	fearful,	and	neutral)	facial	stimuli.	
EEG Recording.	 Continuous	 EEG	 signals	 were	
recorded	 by	 32	 Ag/AgCl	 electrodes	 mounted	 in	
an	 electrode	 cap	 (Waveguard,	 ANT,	 Netherlands)	
according	 to	 the	 international	 10-20	 standard	 and	
additional	 intermediate	 positions.	 Electrooculogram	
(EOG)	 electrodes	were	 placed	 on	 the	 outer	 canthus	
of	 each	 eye,	 inferior	 and	 superior	 to	 the	 left	 orbit,	
so	 as	 to	monitor	 horizontal	 and	 vertical	 oculomotor	
artifacts,	 respectively.	 Electrode	 impedances	 were	
maintained	below	5	kΩ.	A	64-channel	amplifier	(ANT,	
Netherlands)	was	 used	 for	 data	 recording,	 and	ASA	
4.7.1	 software	 was	 used	 for	 data	 acquisition.	 The	
sampling	rate	was	512	sec–1.	EEG	was	recorded	online	
with	a	50-Hz	notch	filter.
ERP Extraction. EEG	data	were	analyzed	off-line	
using	ASA	4.7	(ANT,	Netherlands),	EEGLAB	9.0.8.6.b	
(a	 freely	available	open	source	 toolbox,	http://	www.
sccn.ucsd.edu/eeglab)	 and	 MATLAB	 7.10.0	 (Math	
works,	 USA)	 software.	 Raw	 data	 were	 filtered	with	
a	 band-pass	 filter	 of	 1	 to	 80	 Hz	 and	 referenced	 to	
the	mastoids	 average.	 Similar	 to	 our	 previous	 report	
[33],	 the	eye	movement	artifacts	were	canceled	using	
independent	component	analysis	(ICA).	A	combination	
of	the	efficient	variant	of	fast	ICA	(EFICA)	and	efficient	
weight-adjusted	SOBI	(EWASOBI)	was	chosen	as	 the	
ICA	 method	 using	 ICALAB	 software.	 In	 addition,	
the	 remaining	artifacts	with	deflection	amplitudes	of	
±100	μV	from	the	baseline	were	eliminated	(primarily	
through	 automatic	 artifact	 reduction	 by	 EEGLAB	
9.0.8.6.b	 software	 and	 secondarily,	 through	 visual	
inspection	 made	 by	 an	 expert).	 Artifact-free	 EEG	
recordings	were	 then	 segmented	 into	 epochs	 ranging	
from	 250	 msec	 pre-stimulus	 to	 1,000	 msec	 post-
stimulus.	Each	channel	baseline	epoch	was	corrected	
by	prestimulus	voltage	subtraction.
Feature Extraction. The	N170	component	of	visual	
ERPs	 is	a	negative	waveform	peaking	approximately	
155-190	 msec	 post-stimulus.	 It	 is	 mostly	 observed	
in	 the	 occipito-temporal	 sites	 and,	 as	 is	 	 commonly	
supposed,	 represents	 the	 earliest	 stage	 of	 facial	
structure	encoding	[17,	19].	Our	detection	method	for	
this	component	was	 in	 line	with	earlier	experiments.	
The	 maximum-peak	 amplitude	 and	 latency	 values	
were	automatically	extracted	 from	occipito-temporal	
records	 (P7,	P8)	 [22,	34]	within	 the	 time	window	of	
130	 to	 250	msec,	 and	 all	 peaks	 were	 confirmed	 by	
visual	inspection.
Data Processing.	Mean	values	of	the	amplitude	and	
latency	 were	 statistically	 analyzed	 using	 repeated-
measure	 analysis	 of	 variance	 (ANOVA)	 comprising	
the	following	core	factors:	hemisphere	(left	and	right),	
facial	 expression	 (happy,	 fearful,	 and	 neutral),	 and	
groups	 (patients	 and	 controls).	 Greenhouse-Geisser	
correction	 was	 used	 for	 the	 degrees	 of	 freedom.	 In	
addition,	 to	calculate	 the	direction	and	magnitude	of	
the	 association	between	N170	measures	 and	clinical	
features,	we	applied	the	Spearman’s	rho	nonparametric	
correlation	in	SPSS	17.0.	Throughout	the	experiment,	
differences	with	P	<	0.05	were	considered	significant.
RESULTS
Eight	 participants	 were	 excluded	 from	 the	 study.	
These	included	four	control	subjects	due	to	excessive	
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rejected	trials,	two	patients	due	to	inaccuracies	in	the	
PANSS	scores,	and	finally	 two	other	control	subjects	
in	order	to	better	maintain	group	matching	by	age	and	
sex.	Altogether,	28	patients	(16	men	and		12	women)	
and	28	control	subjects	(16	men	and	12	women)	were	
included	 in	 the	 study	 (details	 are	 summarized	 in	 
Table	1).
The	mean	and	s.e.m.	values	for	the	N170	amplitude	
and	latency	in	response	to	different	facial	expressions	
are	shown	in	Table	2.	The	grand	averages	of	the	N170	
waveforms	across	the	three	types	of	facial	expressions	
(P7/P8)	are	illustrated	in	Fig.	1.
Repeated-measure 	 ANOVA	 demonstrated	 a	
significant	main	effect	of	the	hemisphere	(F	[1,	54]	= 
=	 40.83,	 P	 =	 0.001)	 and	 the	 interaction	 effect	 of	
hemisphere×facial	expression	(F	[2,	108]	=	5.43,	P	= 
=	0.006)	on	the	N170	amplitude.	Pairwise	comparisons	
revealed	 larger	 N170	 peaks	 throughout	 the	 right	
hemisphere	in	both	groups.	No	significant	main	effects	
of	 facial	 expression	 and	 interaction	 effects	 of	 facial	
expression×group,	as	well	as	hemisphere×group	on	the	
N170	amplitude,	were	documented.	Moreover,	the	two	
groups	 showed	no	 significant	 difference	 in	 terms	of	
the	N170	amplitude.		
With	 regards	 to	 the	 N170	 latency,	 repeated-
measure	ANOVA	revealed	a	significant	main	effect	of	
the	 group	 (F	 [1,	 54]	=	4.25,	 	P	 =	 0.044).	The	 result	
of	 pairwise	 comparison	 indicated	 that	 the	 N170	
latency	 tended	 to	 be	 shorter	 in	 the	 left	 hemisphere.	
Moreover,	 for	 schizophrenics,	 further	 analysis	 of	
TABLE 1. Characteristics of the Two Studied Groups (Schizophrenia Patients and Control Subjects)
Т а б л и ц я 1. Характеристики двох обстежених груп (пацієнтів із шизофренією та контрольних суб’єктів) 
Characteristics
Schizophrenia	group	 
(n	=	28)
Control	group 
	(n	=	28)
Intergroup	difference
t P
Age	(years) 33.32	±5.65 32.61	±	6.01 0.45 0.65
Education	(classes,	years) 12.57	±	2.7 15.12	±	3.20 –3.2 0.002
Illness	duration	(years)	 				11.5	±	6.92
PANSS	scores
Positive	symptoms 21.27	±	6.61
Negative	symptoms 21.82	±	6.98
General	 			42.79	±	13.11
Footnote.	Means	±	s.d.	values	are	shown.
F i g. 1.	 Grand-average	 of	 the	
N170	 components	 in	 ERPs	
recorded	 from	 the	 left	 and	 right	
hemispheres	 (P7/P8)	 in	 response	
to	 presentations	 of	 happy	 (A),	
fearful	 (B),	 and	 neutral	 (C)	 face	
images	 among	 the	 schizophrenia	
(1)	and	control	(2)		groups.
Р и с. 1.	 Усереднені	 в	 межах	
груп	 компоненти	 N170,	
відведені	 від	 лівої	 та	 правої	
півкулі	 (P7/P8),	 в	 умовах	
пред’явлення	 зображень	 облич	
зі	 щасливим	 (A),	 переляканим	
(B)	і	нейтральним		(C)	виразом	у	
групі	пацієнтів	із	шизофренією	
(1)	та	в	контрольній	групі	(2).
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(F	 [2,	 108]	=	3.57,	P	=	0.039)	on	 the	N170	 latency.	
Despite	 the	 different	 intergroup	 trend	 of	 the	 N170	
latency	 in	 response	 to	 different	 facial	 expressions	 
(Fig.	 2)	 in	 terms	 of	 the	 time	 course	 and	 priority,	
separate	 post-hoc	 analysis	 between	 different	 facial	
expressions	 in	 each	 group	 showed	 no	 significant	
difference	 for	 the	N170	 latency	 in	 response	 to	 faces	
in	 both	 groups.	 Nevertheless,	 the	 N170	 latency	 in	
response	 to	 fearful	 faces	was	 the	 only	 significantly	
differing	measure	between	 the	 two	groups	 (t	=	2.95,	
P	=	0.005).
No	 relat ionships	 were	 found	 between	 the	
N170	 ampli tude/latency	 and	 negative/general	
psychopathology	 symptoms	 in	 the	 schizophrenia	
group.	However,	the	positive	symptoms	demonstrated	
a	 significant	correlation	with	 the	“left”	amplitude	of	
N170,	as	are	shown	boldfaced	in	Table	3.	
DISCUSSION
The	 aims	 of	 our	 study	 were,	 firstly,	 to	 compare	 the	
ERP	features	of	 the	N170	component	among	patients	
with	 schizophrenia	 and	 healthy	 controls	 when	
passively	 viewing	 the	 posed	 happy,	 fearful,	 and	
neutral	 face	 images	 and,	 secondly,	 to	 investigate	 the	
relationship	 between	 the	 N170	 characteristics	 and	
clinical	 symptoms	 (using	 PANSS)	 of	 schizophrenia.	
The	study	yielded	three	main	results.	First,	in	terms	of	
comparing	the	N170	between	the	two	groups,	patients	
with	 schizophrenia	 exhibited	 longer	 latencies	 and	
smaller	N170	peaks	in	response	to	happy,	fearful,	and	
neutral	faces	regardless	of	their	expressions	than	those	
in	 the	 control	 group.	 Moreover,	 the	 only	 significant	
difference	between	the	two	groups	was	the	disparity	in	
the	N170	latency.	What	is	inferred	from	this	finding	is	
msec
190
185
180
2
1175
170
Happy Fearful Neutral
F i g. 2.	Dependence	of	the	mean	values	of	the	N170	latency,	msec,	
on	the	facial	expression	in	the	presented	images;	1	and	2)	control	
group	and	patients	with	schizophrenia,	respectively.	
Р и с. 2.	 Залежність	 середніх	 величин	 латентного	 періоду	
(мс)	 компонента	 N170	 від	 виразу	 обличчя	 на	 пред’явлених	
зображеннях	 у	 контрольній	 групі	 (1)	 та	 групі	 пацієнтів	 із	
шизофренією	(2).	
TABLE 2. Parameters of Component N170 in Event-Related EEG Potentials Evoked in Response to Presentation of Images of Facial 
Expression
Т а б л и ц я 2. Параметри компонента N170 у складі пов’язаних з подією потенціалів, котрі були викликані пред’явленням 
зображень облич з різними виразами
Parameters Facial	expression
Left	hemisphere Right	hemisphere
schizophrenia	group control	group schizophrenia	group control	group
Amplitude,	mV
fearful –11.94	±	2.15 	–13.57	±	1.55 –16.62	±	2.45 –21.88	±	2.6
happy –10.93	±	2.04 	–11.74	±	1.62 –18.02	±	2.08 –21.79	±	2.7
neutral –11.14	±	1.9 	–10.89	±	1.99 –18.18	±	2.55 –22.39	±	2.6
Lattency,	msec
fearful 	192.72	±	5.33 170.93	±	4.2 183.03	±	3.74 		176.38	±	3.70
happy 			186.5	±	4.11 176.27	±	4.3 180.10	±	2.08 		182.66	±	3.91
neutral 		186.44	±	4.94 	177.24	±	4.09 183.24	±	3.25 		179.96	±	3.48
Footnote.	Means	±	s.e.m.	are	shown.
hemisphere×group	 (F	 [1,	 54]	 =	 4.64,	 P	 =	 0.036)	
interaction	suggested	that,	although	the	N170	response	
to	different	facial	expressions	in	this	group	is	delayed	
in	 both	 hemispheres	 (as	 compared	 to	 the	 controls),	
this	disparity	between	 the	 two	groups	 is	particularly	
significant	 in	 the	 left	hemisphere	 (hemispheres:	 left,	 
t	=	–2.58,	P	=	0.013	vs	right,	t	=	–0.60,	P	=	0.545).	
Repeated-measure	ANOVA	indicated	the	significant	
interaction	 effect 	 of 	 facial 	 expression×group	 
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that,	regardless	of	the	particular	expression,	faces	are	
processed	in	almost	the	same	way	in	the	schizophrenia	
group	as	in	the	control	group;	however,	the	perception	
process	is	carried	out	later.	This	delay	in	the	early	stage	
of	 perception	 may	 possibly	 lead	 to	 face	 recognition	
deficits	among	patients	with	schizophrenia.	To	arrive	
at	 a	 more	 solid	 conclusion	 with	 this	 respect,	 other	
emotional	faces	and	their	related	elicited	components	
should	 be	 investigated.	 This	 finding	 is	 consistent	
with	 other	 reports	 in	 terms	 of	 N170	 deficiencies	 in	
schizophrenia.	According	 to	 Campanella	 et	 al.	 [22],	
subjects	 with	 schizophrenia	 tend	 to	 exhibit	 smaller	
amplitudes	of	P100	 and	N170	with	delayed	 latencies	
when	 assigned	 to	 the	 emotional	 face	 oddball	 task	
(neutral	faces	as	frequent	stimuli,	and	sad,	fearful,	or	
happy	 faces	 as	 target	 stimuli).	 	This	 has	 been	 linked	
to	 deficiencies	 in	 the	 early	 stage	 of	 face	 perception	
among	 these	 patients.	 Turetsky	 et	 al.	 [21]	 reported	
significant	group	differences	for	the	N170	component	
features,	 which	 were	 sensitive	 to	 face	 structural	
encoding	but	not	to	the	affect	modulation	of	the	N250	
component.	 The	 authors	 concluded	 that	 emotional	
face	 recognition	deficits	are	potentially	due	 to	 faulty	
structural	encoding	of	faces	in	the	patient	group	[21].	
Along	with	these	lines,	Caharel	et	al.	[5]	reported	the	
smaller	amplitudes	and	longer	latencies	of	P1	and	N170	
in	response	to	facial	expressions	(disgust,	happy,	and	
neutral)	and	familiarity	tasks.	They	proposed	that	this	
deficit	was	possibly	due	to	a	generalized	dysfunction	
at	 sensory	 (P1)	 and	perceptual	 (N170)	 stages	of	 face	
processing.	Based	on	some	other	reports,	when	patients	
with	schizophrenia	passively	attend	to	emotional	faces,	
their	 N170	 a	 features	 represent	 characteristically	 a	
similar	 pattern.	 Lower	 amplitudes	 and	 prolonged	
latencies	of	the	N170	component,	as	compared	to	those	
in	normal	subjects,	were	shown.	However,	 the	extent	
of	these	dissimilarities	varied	in	different	studies	[19,	
27].	The	findings	vary	among	different	investigations,	
including	ours.	The	inconsistency	in	the	amplitude	of	
N170	in	various	reports	may	be	due	to	the	type	of	the	
task	[22]	or	of	emotional	faces	[5,	21],	and	differences	
in	the	signal	analysis	method	(mean	global	field	power,	
while	we	examined	the	mean	amplitude)	[5,	27].	
In	contrast,	several	authors	have	reported	the	N170	
components	of	almost	the	same	features	in	response	to	
facial	expressions	in	both	groups.	Wynn	et	al.	[35]	pro-
posed	similar	trends	of	P100	and	N170	in	the	schizo-
phrenia	 and	 control	 groups	 in	 response	 to	 fearful,	
angry,	ashamed,	happy,	sad,	and	surprised	faces.	How-
ever,	 they	 found	a	significant	difference	 in	N250	(in	
response	to	emotional	faces)	between	the	two	groups.	
The	 inconsistency	 seen	 between	 the	 above	 data	 and	
that	of	ours	may	at	 least	partly	be	due	 to	 the	differ-
ence	in	time	windows	for	N170	examination	(140-220	
TABLE 3. Correlations between the Amplitude and Latency of Component N170 and Clinical Symptoms in the Schizophrenia Group 
(n = 28)
Т а б л и ц я 3. Кореляція між величинами амплітуди й латентного періоду компонента N170 і виразністю клінічних 
симптомів у групі пацієнтів із шизофренією (n = 28)
N170	parameter/hemisphere
Facial	expressions Positive	symptoms
Negative	
symptoms
General	psychopathology	
symptoms
rho
Amplitude	/	Left fearful –0.57** 0.18 –0.02
happy –0.49** 0.02 –0.13
neutral –0.48** 0.13 –0.05
Latency	/	Left fearful –0.39* –0.15 –0.15
happy –0.28 –0.01 –0.01
neutral –0.29 –0.13 –0.13
Amplitude	/	Right fearful –0.14 0.005 0.005
happy 0.02 0.1 0.1
neutral –0.26 0.02 0.02
Latency	/	Right fearful 0.08 –0.08 –0.08
happy –0.05 –0.15 –0.15
neutral –0.26 –0.2 –0.20
Footnotes.	rho)	Spearman’s	rank	correlation	coefficient.	One	and	two	asterisks	show	cases	of	significant	correlations	with	P	<	0.05	and	 
<	0.04,	respectively.	Positive	symptoms	demonstrating	a	significant	correlation	with	the	“left”	amplitude	and	latency	of	component	N170	
are	shown	boldfaced.	
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msec	 in	other	studies	vs	130-250	msec	 in	 the	current	
investigation).
Second,	our	findings	have	demonstrated	significant-
ly	 different	 trends	 for	 the	N170	 latency	 in	 response	
to	 fearful,	happy,	 and	neutral	 faces	between	 the	 two	
groups.	 In	our	control	group,	 regardless	of	 the	hemi-
sphere	 effect	 of	 facial	 expressions,	 the	 fastest	N170	
response	was	evoked	 to	presentation	of	 fearful	 faces	
(followed	by	happy	and	neutral	faces).	Conversely,	re-
sponses	to	fearful	faces	were	the	slowest	in	the	schizo-
phrenia	group,	as	compared	to	other	facial	expressions	
(Fig.	2).	Given	the	above,	the	emotional	face	percep-
tion	 in	 schizophrenia	 patients	 compared	 to	 controls	
turned	out	 to	be	not	only	more	delayed	but	also	hav-
ing	different	characteristic	 features.	As	expected,	 the	
fearful	expression	 (as	a	 threatening	stimulus),	which	
requires	a	faster	response	to	danger,	fear,	and	misery,	
was	 related	 to	 the	 shortest-latency	N170	 in	 the	 nor-
mal	group.	In	contrast,	the	schizophrenia	group	failed	
to	show	such	sensitivity	to	fearful	stimuli.	The	above	
finding	is	in	line	with	those	of	Campanella	et	al.	[22],	
Lee	et	al.	 [27],	and	Kirihara	et	al.	 [36].	As	was	 indi-
cated	in	some	studies,	the	difference	in	emotional	face	
responses	between	the	 two	groups	 is	seen	 in	 the	sub-
sequent	components,	mainly	the	N250	[35].	According	
to	Herrmann	et	al.	and	An	et	al.	[28,	37],	the	emotional	
face	perception	deficits	 in	schizophrenia	 is	predomi-
nantly	due	 to	 the	 failure	 in	 the	decoding	phase	and	a	
decrease	 in	 the	positive	amplitudes	at	300	msec	over	
the	parietal	brain	areas.	We	have	not	studied	other	ERP	
components;	however,	we	can	expect	that	this	dispar-
ity	in	early-stage	face	processing	can	potentially	affect	
the	subsequent	components,	such	as	N250	or	P300.
On	 the	 other	 hand,	 according	 to	 the	 study	 of	Gur	
et	 al.	 [38],	 the	 performance	 of	 schizophrenia-group	
patients	with	 the	 flat	 affect	was	 poorer	 than	 that	 in	
the	healthy	group,	and	 this	 impairment	corelated	ex-
clusively	with	positive	 clinical	 symptoms.	Although	
the	 methodology	 and	 task	 type	 of	 the	 above	 study	
is	entirely	different	 from	 those	 in	our	work,	we	may	
atribute	 link	 longer	 latencies	of	N170	(modulated	by	
positive	symptoms)	to	a	blunted	affect	seen	in	schizo-
phrenia.
Third,	considering	our	own	results,	the	amplitude	of	
the	left	N170	in	response	to	happy,	fearful,	and	neutral	
faces	and	also	the	latency	of	the	left	N170	in	response	
to	 fearful	 faces	are	modulated	by	positive	 symptoms	
in	patients	with	schizophrenia.	In	other	words,	regard-
less	of	the	type	of	facial	expressions,	a	greater	sever-
ity	of	positive	symptoms	induces	more	engagement	of	
the	 neural	 processors	 during	 the	 face	 encoding	 (the	
absolute	value	of	 the	N170	amplitude).	The	 relation-
ship	 between	 positive	 symptoms	 and	 the	 amplitude	
of	N170	is	consistent	with	Campanella	et	al.	[22]	and	
Turetsky	et	al.	[21];	however,	they	found	this	relation-
ship	with	bilateral	N170s.	As	opposed	to	Thoma	et	al.	
[39]	who	found	that	the	negative	symptoms	in	patients	
with	schizophrenia	correlated	with	the	dysfunction	of	
right-hemisphere	and	sensory	gating	impairments,	Hi-
gashima	 et	 al.	 [40]	 demonstrated	 an	 association	 be-
tween	the	left	posterior	temporal	region	with	positive	
symptoms	presentations,	such	as	delusions	and	thought	
disorders	 [40].	As	expected,	 the	correlation	between	
abnormal	activation	of	the	left	medial	and	lateral	tem-
poral	regions	with	positive	symptoms	may	be	one	rea-
son	for	 the	modulation	of	 the	 left	N170	amplitude	 in	
response	to	facial	expression.
From	a	 neuroimaging	point	 of	 view,	 results	 of	 an	
fMRI	 study	 in	 schizophrenia	 have	 demonstrated	
the	 relationship	 between	 clinical	 symptoms	 and	
impairments	of	some	particular	brain	regions	that	are	
	typically	 involved	during	emotional	 tasks.	Since	 the	
correlation	between	positive	symptoms	and	the	activity	
of	 the	 amygdala,	 hippocampal/parahippocampal	
structures,	 and	 medial	 prefrontal	 cortex	 has	 been	
established	 [2],	 it 	 may	 be	 concluded	 that	 the	
impairment	 of	 some	 key	 regions,	 such	 as	 amygdala	
(which	 plays	 an	 important	 role	 in	 detection	 of	
emotional	and,	especially,	fearful	faces)	is	influenced	
by	 positive	 symptoms.	 Moreover,	 the	 severity	 of	
positive	 symptoms	 may	 influence	 compensatory	
mechanisms	in	brain	circuits	[41].	The	need	to	further	
explanation	 of	 these	 possible	 mechanisms	 makes	
additional	basic	and	complex	facial	expression	studies	
worthwhile.
Finally,	 the	main	 limitations	 of	 our	 study	 should	
be	noted.	Firstly,	all	participants	 in	 the	patient	group	
were	on	medication	that	could	not	be	changed	because	
of	ethical	 reasons.	So,	we	did	not	examine	 the	effect	
of	 medicine	 on	 the	 N170	 component	 that	 can	 be	
influenced	by	some	 types	of	drugs.	Secondly,	we	did	
not	compare	the	facial	perception	in	different	types	of	
schizophrenia,	and	this	was	due	to	the	limited	sample	
size.
To	conclude,	the	impairment	of	“facial	expression”	
perception	 in	 schizophrenia	 is	 potentially	 linked	 to	
delays	 in	 face	 perception	 per se,	 regardless	 of	 the	
expressions.	 Interestingly,	 the	 amplitude	of	 the	 left-
hemisphere	N170	 in	 response	 to	 happy,	 fearful,	 and	
neutral	 faces	 and	 the	 latency	 of	 the	 N170	 evoked	
by	 fearful	 faces	 were	 influenced	 by	 the	 severity	 of	
positive	 symptoms	 in	 schizophrenia.	 The	 delay	 in	
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perception	 of	 fearful	 faces	 in	 schizophrenia	 can	 be	
considered	 as	 one	 of	 the	 many	 reasons	 explaining	
inappropriate	reactions	of	these	patients	to	threatening	
conditions.
The	ethical	protocol	of	this	study	was	based	on	the	Helsinki	
Declaration,	 and	 written	 informed	 consent	 signed	 by	 all	
participants	prior	to	their	enrollment	was	obtained.
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Р	е	з	ю	м	е
У	пацієнтів,	котрі	страждають	на	шизофренію,	розпізнаван-
ня	виразів	обличчя	є	серйозно	порушеним.	Оскільки	проце-
си,	що	зумовлюють	подібний	дефіцит,	вивчені	недостатньо,	
ми	намагалися	дослідити	співвідношення	сприйняття	вира-
зів	обличчя	та	клінічних	симптомів	у	пацієнтів	 із	цим	за-
хворюванням.	В	обстежувану	групу	ввійшли	28	пацієнтів	із	
діагнозом	шизофренія	та	28	дорослих	суб’єктів;	групи	були	
узгоджені	в	статевому	та	віковому	аспектах.	У	представни-
ків	цих	двох	 груп	вимірювали	та	порівнювали	 	 амплітуду	
й	латентний	період	компонента	N170	у	складі	пов’язаних	з	
подією	потенціалів,	викликаних	пред’явленням	зображень	
облич	 зі	щасливим,	 переляканим	 і	 нейтральним	 виразом.	
Потім	оцінювали	взаємозв’язок	параметрів	N170	з	оцінка-
ми	клінічних	симптомів	шизофренії	згідно	зі	шкалою	пози-
тивних	 і	негативних	синдромів	 (PANSS).	Розвиток	компо-
нента	N170	після		пред’явлення	зображень	облич	з	різними	
виразами	 відбувався	 у	 пацієнтів	 із	 шизофренією	 істотно	
пізніше,	ніж	у	здорових	контрольних	суб’єктів	[F	(1,	54)	= 
=	4.25,	P	=	0.044].	N170	після	пред’явлення	переляканих	об-
лич	(порівняно	зі	щасливими	та	нейтральними)		розвивався	
у	суб’єктів	контрольної	групи	з	мінімальною	затримкою,	а	
у	шизофреників	він	виникав	значно	пізніше.	Інтенсивність	
позитивних	симптомів	у	шизофреників	корелювала	з	амп-
літудами	N170	у	лівій	півкулі	після	пред’явлення	як	щас-
ливих,	 так	 і	переляканих	 і	нейтральних	облич.	Наші	 спо-
стереження	показують,	що	дефектність	сприйняття	виразу	
обличчя	 у	 пацієнтів,	 хворих	на	шизофренію,	 пов’язана	 із	
затримкою	відповідей	ЦНС,	 і	на	таку	дефектність	впливає	
тяжкість	позитивних	симптомів.	Очевидна	затримка	сприй-
няття	облич	з	переляканим	виразом	у	пацієнтів	із	шизофре-
нією	може	частково	пояснювати	неадекватність	 їх	реакцій	
на	загрозливі	ситуації.	
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